Stiehl A, Raedsch R, Rudolph G, Walker S
Hepatology. 1984 Jan-Feb;4(1):107-11. doi: 10.1002/hep.1840040119.
In five patients with radiolucent gallstones, the effect of ursodeoxycholic acid (Urso) in doses of 250, 500, 750, 1,000, and 1,250 mg per day on biliary lipid and bile acid composition was studied. Biliary cholesterol decreased from 8.8 +/- 0.8 mole% to 4.4 +/- 0.2 mole% at 500 mg Urso per day (7.1 mg per kg) and to 4.2 +/- 0.3 mole% at 750 mg Urso per day (10.7 mg per kg). Administration of 1,000 or 1,250 mg Urso per day produced no further decrease of biliary cholesterol. The biliary content of phospholipids and total bile acids remained unchanged. During Urso treatment, the relative amounts of glyco-Urso and tauro-Urso in bile increased. Glyco-Urso reached a plateau at 49.1 +/- 2.1% of total bile acids during treatment with 1,000 mg Urso per day, and tauro-Urso increased up to 4.3 +/- 1.5% of total bile acids at 250 mg Urso per day. Simultaneously cholic acid, chenodeoxycholic acid, deoxycholic acid, and lithocholic acid decreased. The data indicate that Urso treatment reduces biliary cholesterol efficiently already at a dose of 500 mg per day; biliary bile acid composition changes up to 1,000 mg Urso per day. Doses greater than 1,000 mg per day produced no additional alterations in bile composition.
对5例存在透X线胆结石的患者,研究了每天服用250、500、750、1000和1250毫克熊去氧胆酸(优思弗)对胆汁脂质和胆汁酸成分的影响。每天服用500毫克优思弗(每千克体重7.1毫克)时,胆汁胆固醇从8.8±0.8摩尔%降至4.4±0.2摩尔%;每天服用750毫克优思弗(每千克体重10.7毫克)时,降至4.2±0.3摩尔%。每天服用1000或1250毫克优思弗,胆汁胆固醇未进一步降低。胆汁中磷脂和总胆汁酸含量保持不变。在优思弗治疗期间,胆汁中甘氨熊去氧胆酸和牛磺熊去氧胆酸的相对含量增加。每天服用1000毫克优思弗治疗时,甘氨熊去氧胆酸达到总胆汁酸的49.1±2.1%的平台期,每天服用250毫克优思弗时,牛磺熊去氧胆酸增加至总胆汁酸的4.3±1.5%。同时,胆酸、鹅去氧胆酸、脱氧胆酸和石胆酸减少。数据表明,优思弗治疗每天500毫克的剂量就已能有效降低胆汁胆固醇;每天服用1000毫克优思弗时胆汁酸成分发生变化。每天剂量大于1000毫克时,胆汁成分无额外改变。